Jiangsu Hengrui Pharmaceuticals Co., Ltd

Hengrui Pharma (Jiangsu Hengrui Pharmaceuticals Co., Ltd.) is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. Its therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology. Hengrui has ranked on Pharma Exec’s annual list of the top 50 global pharmaceutical companies for seven consecutive years. According to the list of the world's top 25 pipeline-scale pharmaceutical companies released by Citeline, an internationally renowned consulting organization, Hengrui has remained on the list for four consecutive years, and it ranks second globally in the number of independently developed pipelines.